Evidence map›Paper›PMID 36979837›Full record

ArticleBiomedicines2023

Low-Dose Radiotherapy for Patients with Pneumonia Due to COVID-19: A Single-Institution Prospective Study.

Tomasz Wojciech Rutkowski, Jerzy Jaroszewicz, Damian Piotrowski, Krzysztof Ślosarek, Barbara Sobala-Szczygieł, Dorota Słonina, Bożena Włostowska, Dawid Bodusz, Maciej Piasecki, Michał Nachlik and 6 more

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Tomasz Wojciech RutkowskiMaria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, ul. Wybrzeże Armii Krajowej 15, 44-100 Gliwice, Poland.ORCID 0000-0003-2735-5664
Jerzy JaroszewiczDepartment of Infectious Diseases and Hepatology, Medical University of Silesia, 41-902 Bytom, Poland.
Damian PiotrowskiDepartment of Infectious Diseases and Hepatology, Medical University of Silesia, 41-902 Bytom, Poland.ORCID 0000-0001-7044-2523
Krzysztof ŚlosarekMaria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, ul. Wybrzeże Armii Krajowej 15, 44-100 Gliwice, Poland.
Barbara Sobala-SzczygiełDepartment of Infectious Diseases and Hepatology, Medical University of Silesia, 41-902 Bytom, Poland.
Dorota SłoninaMaria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, ul. Wybrzeże Armii Krajowej 15, 44-100 Gliwice, Poland.
Bożena WłostowskaDepartment of Infectious Diseases and Hepatology, Medical University of Silesia, 41-902 Bytom, Poland.
Dawid BoduszMaria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, ul. Wybrzeże Armii Krajowej 15, 44-100 Gliwice, Poland.
Maciej PiaseckiDepartment of Infectious Diseases and Hepatology, Medical University of Silesia, 41-902 Bytom, Poland.
Michał NachlikMaria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, ul. Wybrzeże Armii Krajowej 15, 44-100 Gliwice, Poland.
Barbara Oczko-GrzesikDepartment of Infectious Diseases and Hepatology, Medical University of Silesia, 41-902 Bytom, Poland.
Adam GądekMaria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, ul. Wybrzeże Armii Krajowej 15, 44-100 Gliwice, Poland.ORCID 0000-0002-2620-5448
Dorota KowalMaria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, ul. Wybrzeże Armii Krajowej 15, 44-100 Gliwice, Poland.
Roman RutkowskiMaria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, ul. Wybrzeże Armii Krajowej 15, 44-100 Gliwice, Poland.
Elżbieta Wojarska-TrędaMaria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, ul. Wybrzeże Armii Krajowej 15, 44-100 Gliwice, Poland.
Krzysztof SkładowskiMaria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, ul. Wybrzeże Armii Krajowej 15, 44-100 Gliwice, Poland.
The Maria Sklodowska-Curie National Research Institute of Oncology · PLMedical University of Silesia · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeResults of the low-dose radiation therapy (LDRT) in patients with pneumonia due to COVID-19 has been presented.

methodsFifteen patients received a single-fraction radiation dose of 1 Gy to the bilateral lungs due to pre-ARDS pneumonia in the course of COVID-19. Follow-up was performed on days 1, 3, 5, 7, 14 after LDRT.

resultsEleven patients (73%) were released up until day 28. Median hospitalization was 20 days; 28-day mortality was 13%. Median O

conclusionLDRT is feasible, well tolerated and may translate to early clinical recovery in patients with severe pneumonia. Further studies are needed to determine optimal candidate, time and dose of LDRT for COVID-19 patients with pneumonia.

Indexed as

COVID-19cytokine storminflammationlow dose radiotherapypneumonia

Identifiers

PMID36979837
PMCPMC10045009
OpenAlexW4324054835

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read36
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.